← All organizations
Highest phase reached
Phase 3
First clinical trial
Jun 1, 2017Last known activity
Apr 15, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (4 distinct, 3 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (3)
- NCT06344169OfficialPhase 2/Phase 3Apr 15, 2024
- NCT05454865Overall official - principal investigatorN/AJan 1, 2022
- NCT02813512Overall official - principal investigatorPhase 1Jun 1, 2017
Details
- Last known activity
- Apr 15, 2024